A patient with a primary lung neuroendocrine tumour and 88 CT-visible metastases requested and consented to rapid autopsy, providing a rare opportunity to study tumour evolution and heterogeneity in a single patient. We have embarked on a multi-layered genomic investigation, augmenting clinical notes and imaging, to build a personalised evolutionary model of the disease progression. Following comprehensive ethical consultation the patient and her extended family provided informed consent to collection of tumours through rapid autopsy (HDEC 13/NTA/69/AM08). Both formalin fixed, paraffin embedded (FFPE) and fresh frozen samples were collected from the 89 lesions and annotated comprehensively. Lesions were sampled extensively where large and likely heterogeneous. From an initial 30 FFPE tumour samples, representing a broad spatial distribution of the patient's total tumour burden, DNA whole exome sequencing (WES), transcriptome mRNA sequencing and RNA microarray analysis was completed, to provide a bank of genomic information to guide evolutionary investigations. We have built statistical evolutionary phylogenetic models using Bayesian software BEAST2 from differences observed across the genomic data to produce a broad evolutionary picture encompassing single nucleotide variants (SNVs) and copy number variants (CNVs).
A rare research opportunity.
A patient with a primary lung neuroendocrine tumour and 88 CT-visible metastases requested and consented to rapid autopsy, providing a rare opportunity to study tumour evolution and heterogeneity in a single patient. We have embarked on a multi-layered genomic investigation, augmenting clinical notes and imaging, to build a personalised evolutionary model of the disease progression. Following comprehensive ethical consultation the patient and her extended family provided informed consent to collection of tumours through rapid autopsy (HDEC 13/NTA/69/AM08). Both formalin fixed, paraffin embedded (FFPE) and fresh frozen samples were collected from the 89 lesions and annotated comprehensively. Lesions were sampled extensively where large and likely heterogeneous. From an initial 30 FFPE tumour samples, representing a broad spatial distribution of the patient's total tumour burden, DNA whole exome sequencing (WES), transcriptome mRNA sequencing and RNA microarray analysis was completed, to provide a bank of genomic information to guide evolutionary investigations. We have built statistical evolutionary phylogenetic models using Bayesian software BEAST2 from differences observed across the genomic data to produce a broad evolutionary picture encompassing single nucleotide variants (SNVs) and copy number variants (CNVs).
Tumour Heterogeneity.
For cancer biologists, understanding the evolution and resulting genomic heterogeneity of multiple tumours in a single patient is an important goal. For oncologists, genomic maps of multiple tumours in each patient, when combined with histology and imaging studies, could bring a step change to precision oncology. This study aims to model the biology of tumour evolution in a patient with a lung neuroendocrine tumour, in order to improve clinical understanding of the likely genetic heterogeneity in neuroendocrine tumour patients. SLIT1  CHIT1  IDI2-AS1  SLC35E3  HOOK2  IRAK2  MYO3B   MASTL  DNAJC4  SPINT1  EGFLAM  BCYRN1  TEKT5  SLFN5  COL5A1  CCDC88C  GIGYF2  CAMSAP1  SAMD1   SRGAP2  ADAM11  NKAIN4  intergenic  ADAMTS7  PTPRM  IFI16  CYTH1  RNF214  SGCG  GNB2  RRP12   PCDHA1  NR3C1  ZSWIM6  TM2D3  LHX1  MMP9  CCDC39  OCRL 
Lung NET diagnosis

Presence of few additional SNVs in sampling sites within first observed lung lesion
Lack of additional SNVs in sampling sites within first observed lung lesion provides support for the disseminated disease to have originated in the lower right lung lobe, and provides insight into the likely genomic changes present in early lesions.
Distinct shared SNVs identify two lineage of distant metastatic tumours
The first distant metastatic lineage (purple) is characterized by a pattern of 7 SNVs shared by 11 sampling sites, including sampling sites within first observed lung lesion, suggesting that this lineage arose within cells of the original lung lesion. The second distant metastatic lineage (teal) is characterized by loss of a chunk of chromosome 12 as well as 5 shared SNVs.
Evolutionary Lineages Displayed by Body Position
The two genomically distinct distant metastatic lineages (coloured as above) are spatially dispersed around the patient's body.
Patient and family requested and consented to rapid autopsy for research purposes
Future Direction
This poster represents preliminary findings from evolutionary analyses. Key next steps include:
• Working in collaboration with computational biology collaborators to produce more sophisticated and fine-tuned mathematical evolutionary models • Producing a combined analysis that brings in RNA expression and methylation data • Expanding the cohort of sampling sites analysed to more locations, including enhanced representation of the large lung and pancreatic lesions (12 further sampling sites) • Applying the analysis methods worked up on this study to further evolutionary cohorts
